MYCN and metastatic neoplasm: In this same position, three SNPs, namely CASC15, CASC15-S, and CASC14, were identified by Genome-Wide Association Study (GWAS) and associated with metastatic disease, amplification of MYCN oncogene, and more advanced disease [13,14,15].